Generate a comprehensive and actionable clinical summary paragraph for Patient 05353d46-bac6-a5a7-def0-7696db01e81a Hickle134 Marlena558 female 1968-05-28 211 Cummings Village Chester VA 23836. Summarize in a one A4 page length report patient's medical history, treatment course, and include relevant clinical information, advice, and a clear course of action. Ensure the summary is concise yet informative, enabling doctors to effectively engage with the patient and guide their ongoing care given this data information: Condition Received higher education (finding) Condition Limited social contact (finding) Diagnosis Report History and physical note 1986-07-22 02:30:10+10:00 Condition Full-time employment (finding) Condition Stress (finding) Diagnosis Report History and physical note 1987-07-28 02:30:10+10:00 Condition Stress (finding) Diagnosis Report History and physical note 1993-08-03 02:30:10+10:00 Condition Full-time employment (finding) Diagnosis Report History and physical note 1996-08-06 02:30:10+10:00 Condition Miscarriage in first trimester Diagnosis Report History and physical note 1998-06-09 02:30:10+10:00 Condition Social isolation (finding) Diagnosis Report History and physical note 1999-08-10 02:30:10+10:00 Diagnosis Report History and physical note 2000-03-10 04:00:40+11:00 Condition Full-time employment (finding) Condition Stress (finding) Diagnosis Report History and physical note 2002-08-13 02:30:10+10:00 Condition Limited social contact (finding) Diagnosis Report History and physical note 2005-08-16 02:30:10+10:00 Condition Osteoarthritis of knee Diagnosis Report History and physical note 2010-08-02 02:30:10+10:00 Condition Not in labor force (finding) Diagnosis Report History and physical note 2012-06-12 02:30:10+10:00 Medication 389221 Etonogestrel 68 MG Drug Implant active Diagnosis Report History and physical note 2012-11-23 04:17:11+11:00 Condition Medication review due (situation) Condition Body mass index 30+ - obesity (finding) Condition Full-time employment (finding) Condition Stress (finding) Observation final Body Height 160.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} Observation final Body Weight 77.3 kg Observation final Body mass index (BMI) [Ratio] 30.07 kg/m2 Observation final Blood pressure panel with all children optional 76 mm[Hg] 100 mm[Hg] Observation final Heart rate 66 /min Observation final Respiratory rate 14 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 119.53 mg/dL Observation final Triglycerides 143.54 mg/dL Observation final Low Density Lipoprotein Cholesterol 34.61 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 56.22 mg/dL Observation final Leukocytes [#/volume] in Blood by Automated count 4.8912 10*3/uL Observation final Erythrocytes [#/volume] in Blood by Automated count 5.4087 10*6/uL Observation final Hemoglobin [Mass/volume] in Blood 14.229 g/dL Observation final Hematocrit [Volume Fraction] of Blood by Automated count 42.857 % Observation final MCV [Entitic volume] by Automated count 93.766 fL Observation final MCH [Entitic mass] by Automated count 31.502 pg Observation final MCHC [Mass/volume] by Automated count 35.558 g/dL Observation final Erythrocyte distribution width [Entitic volume] by Automated count 39.459 fL Observation final Platelets [#/volume] in Blood by Automated count 355.94 10*3/uL Observation final Platelet distribution width [Entitic volume] in Blood by Automated count 198.8 fL Observation final Platelet mean volume [Entitic volume] in Blood by Automated count 10.984 fL Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 7 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2014-06-17T02:30:10+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2014-06-17 02:30:10+10:00 Diagnosis Report CBC panel - Blood by Automated count 2014-06-17 02:30:10+10:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2014-06-17 03:39:03+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2014-06-17 04:18:38+10:00 Diagnosis Report History and physical note 2014-06-17 02:30:10+10:00 Medication 1000126 1 ML medroxyprogesterone acetate 150 MG/ML Injection active Diagnosis Report History and physical note 2014-11-13 04:46:16+11:00 Diagnosis Report History and physical note 2015-11-08 05:04:05+11:00 Observation final Body Height 160.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} Observation final Body Weight 71.1 kg Observation final Body mass index (BMI) [Ratio] 27.67 kg/m2 Observation final Blood pressure panel with all children optional 77 mm[Hg] 104 mm[Hg] Observation final Heart rate 66 /min Observation final Respiratory rate 12 /min Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 1 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 3 {score} Observation final Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 20 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2016-06-21T02:30:10+10:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2016-06-21 03:34:48+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2016-06-21 04:17:00+10:00 Diagnosis Report PHQ-9 quick depression assessment panel [Reported.PHQ] 2016-06-21 04:44:22+10:00 Diagnosis Report History and physical note 2016-06-21 02:30:10+10:00 Diagnosis Report History and physical note 2016-12-06 03:30:10+11:00 Diagnosis Report History and physical note 2017-10-28 05:04:05+11:00 Condition Limited social contact (finding) Observation final Body Height 160.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} Observation final Body Weight 71.1 kg Observation final Body mass index (BMI) [Ratio] 27.67 kg/m2 Observation final Blood pressure panel with all children optional 77 mm[Hg] 92 mm[Hg] Observation final Heart rate 73 /min Observation final Respiratory rate 13 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 172.4 mg/dL Observation final Triglycerides 123.45 mg/dL Observation final Low Density Lipoprotein Cholesterol 92.14 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 55.57 mg/dL Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 1 {score} Observation final Total score [DAST-10] 1 {score} Immunization completed zoster vaccine, live 2018-05-29T02:30:10+10:00 Immunization completed Influenza, seasonal, injectable, preservative free 2018-05-29T02:30:10+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2018-05-29 02:30:10+10:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2018-05-29 03:29:25+10:00 Diagnosis Report Drug Abuse Screening Test-10 [DAST-10] 2018-05-29 04:09:20+10:00 Diagnosis Report History and physical note 2018-05-29 02:30:10+10:00 Diagnosis Report History and physical note 2018-11-06 03:30:10+11:00 Condition Medication review due (situation) Condition Not in labor force (finding) Observation final Body Height 160.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} Observation final Body Weight 71.1 kg Observation final Body mass index (BMI) [Ratio] 27.67 kg/m2 Observation final Blood pressure panel with all children optional 72 mm[Hg] 97 mm[Hg] Observation final Heart rate 62 /min Observation final Respiratory rate 14 /min Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Immunization completed zoster vaccine, live 2019-06-04T02:30:10+10:00 Immunization completed Influenza, seasonal, injectable, preservative free 2019-06-04T02:30:10+10:00 Immunization completed Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed 2019-06-04T02:30:10+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2019-06-04 04:03:59+10:00 Diagnosis Report History and physical note 2019-06-04 02:30:10+10:00 Condition Viral sinusitis (disorder) Diagnosis Report History and physical note 2019-07-04 21:30:10+10:00 Condition Medication review due (situation) Condition Hyperlipidemia Condition Full-time employment (finding) Observation final Cholesterol [Mass/volume] in Serum or Plasma 293.58 mg/dL Observation final Triglycerides 384.57 mg/dL Observation final Low Density Lipoprotein Cholesterol 125.84 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 49.077 mg/dL Observation final Glucose [Mass/volume] in Blood 70.11 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 9.13 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.206 mg/dL Observation final Calcium [Mass/volume] in Blood 9.3 mg/dL Observation final Sodium [Moles/volume] in Blood 140.09 mmol/L Observation final Potassium [Moles/volume] in Blood 4.7 mmol/L Observation final Chloride [Moles/volume] in Blood 108.81 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 26.77 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 82.845 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.2643 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 4.1218 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 3.2471 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.23506 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 31.741 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 47.208 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 9.0991 U/L Observation final Body Height 160.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} Observation final Body Weight 71.1 kg Observation final Body mass index (BMI) [Ratio] 27.67 kg/m2 Observation final Blood pressure panel with all children optional 69 mm[Hg] 98 mm[Hg] Observation final Heart rate 73 /min Observation final Respiratory rate 13 /min Observation final Leukocytes [#/volume] in Blood by Automated count 4.9061 10*3/uL Observation final Erythrocytes [#/volume] in Blood by Automated count 4.3784 10*6/uL Observation final Hemoglobin [Mass/volume] in Blood 12.497 g/dL Observation final Hematocrit [Volume Fraction] of Blood by Automated count 48.668 % Observation final MCV [Entitic volume] by Automated count 80.428 fL Observation final MCH [Entitic mass] by Automated count 32.732 pg Observation final MCHC [Mass/volume] by Automated count 33.424 g/dL Observation final Erythrocyte distribution width [Entitic volume] by Automated count 43.086 fL Observation final Platelets [#/volume] in Blood by Automated count 192.33 10*3/uL Observation final Platelet distribution width [Entitic volume] in Blood by Automated count 494.71 fL Observation final Platelet mean volume [Entitic volume] in Blood by Automated count 9.8219 fL Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 1 {score} Observation final Total score [HARK] 0 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2020-06-09T02:30:10+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2020-06-09 02:30:10+10:00 Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2020-06-09 02:30:10+10:00 Diagnosis Report CBC panel - Blood by Automated count 2020-06-09 02:30:10+10:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2020-06-09 03:43:12+10:00 Diagnosis Report Humiliation, Afraid, Rape, and Kick questionnaire [HARK] 2020-06-09 04:17:35+10:00 Diagnosis Report History and physical note 2020-06-09 02:30:10+10:00 Diagnosis Report History and physical note 2020-06-30 02:30:10+10:00 Condition Medication review due (situation) Condition Limited social contact (finding) Condition Stress (finding) Observation final Body Height 160.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} Observation final Body Weight 71.1 kg Observation final Body mass index (BMI) [Ratio] 27.67 kg/m2 Observation final Blood pressure panel with all children optional 72 mm[Hg] 102 mm[Hg] Observation final Heart rate 61 /min Observation final Respiratory rate 15 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 114.07 mg/dL Observation final Triglycerides 118.5 mg/dL Observation final Low Density Lipoprotein Cholesterol 33.66 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 56.71 mg/dL Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2021-06-15T02:30:10+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2021-06-15 02:30:10+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2021-06-15 03:57:41+10:00 Diagnosis Report History and physical note 2021-06-15 02:30:10+10:00 Observation final Glucose [Mass/volume] in Blood 83.59 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 7.27 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.9904 mg/dL Observation final Calcium [Mass/volume] in Blood 8.77 mg/dL Observation final Sodium [Moles/volume] in Blood 139.59 mmol/L Observation final Potassium [Moles/volume] in Blood 4.69 mmol/L Observation final Chloride [Moles/volume] in Blood 101.79 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 22.05 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 81.53 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.091 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 5.3066 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.6696 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.76466 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 105.88 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 36.659 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 20.515 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 172.19 mg/dL Observation final Triglycerides 179.51 mg/dL Observation final Low Density Lipoprotein Cholesterol 149.06 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 60.057 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2021-06-30 02:30:10+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2021-06-30 02:30:10+10:00 Diagnosis Report History and physical note 2021-06-30 02:30:10+10:00 Immunization completed SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL 2021-08-10T02:30:10+10:00 Diagnosis Report History and physical note 2021-08-10 02:30:10+10:00 Condition Social isolation (finding) Observation final Body Height 160.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} Observation final Body Weight 71.1 kg Observation final Body mass index (BMI) [Ratio] 27.67 kg/m2 Observation final Blood pressure panel with all children optional 75 mm[Hg] 103 mm[Hg] Observation final Heart rate 71 /min Observation final Respiratory rate 14 /min Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Observation final Total score [AUDIT-C] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2022-06-21T02:30:10+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2022-06-21 03:53:16+10:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2022-06-21 04:25:36+10:00 Diagnosis Report History and physical note 2022-06-21 02:30:10+10:00 Observation final Glucose [Mass/volume] in Blood 97.78 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 15.55 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.3735 mg/dL Observation final Calcium [Mass/volume] in Blood 9.82 mg/dL Observation final Sodium [Moles/volume] in Blood 141.02 mmol/L Observation final Potassium [Moles/volume] in Blood 4.02 mmol/L Observation final Chloride [Moles/volume] in Blood 109.19 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 22.74 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 74.527 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.2616 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 4.9325 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.8861 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.21045 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 46.895 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 33.179 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 6.3971 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 175.82 mg/dL Observation final Triglycerides 120.99 mg/dL Observation final Low Density Lipoprotein Cholesterol 93.142 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 67.388 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2022-06-30 02:30:10+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2022-06-30 02:30:10+10:00 Diagnosis Report History and physical note 2022-06-30 02:30:10+10:00 Observation final Body Height 160.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} Observation final Body Weight 71.1 kg Observation final Body mass index (BMI) [Ratio] 27.67 kg/m2 Observation final Blood pressure panel with all children optional 69 mm[Hg] 99 mm[Hg] Observation final Heart rate 72 /min Observation final Respiratory rate 12 /min Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 0 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 {score} Observation final Total score [AUDIT-C] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2023-06-27T02:30:10+10:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2023-06-27 03:46:46+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2023-06-27 04:20:11+10:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2023-06-27 04:58:22+10:00 Diagnosis Report History and physical note 2023-06-27 02:30:10+10:00 Observation final Glucose [Mass/volume] in Blood 95.78 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 15.47 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.6936 mg/dL Observation final Calcium [Mass/volume] in Blood 8.79 mg/dL Observation final Sodium [Moles/volume] in Blood 139.04 mmol/L Observation final Potassium [Moles/volume] in Blood 3.8 mmol/L Observation final Chloride [Moles/volume] in Blood 103.12 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 21.32 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 65.67 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.2635 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 5.3829 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 3.1063 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.7303 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 90.662 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 42.304 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22.89 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 189.11 mg/dL Observation final Triglycerides 192.2 mg/dL Observation final Low Density Lipoprotein Cholesterol 147.14 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 45.084 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2023-06-30 02:30:10+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2023-06-30 02:30:10+10:00 Diagnosis Report History and physical note 2023-06-30 02:30:10+10:00